Bookselling company Orell Füssli Thalia acquired a stake as lead investor in the digital community platform Evrlearn. With the new partnership, both companies are strengthening their educational activities in B2C and B2B.
Tags :David Jenny
EnBiotix, a Boston-based biotech company focused on rare diseases, is merging with Swiss oncology and antimicrobial resistance-focused company Polyphor. A merger agreement under which Polyphor will use all of EnBiotix’s outstanding share capital in
